Not Tagged
nrg oncology
['biomarker', 'cobra']
. s dr. patrick boland &amp; colleagues present phase ii/iii study of circulating tumor dna as a predictive biomarker in adjuvant chemotherapy in patients with stage ii #colon cancer: nrg-gi005 (cobra). 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.